Antimalarial drug resistance in Africa: Strategies for monitoring and deterrence

Current Topics in Microbiology and Immunology

Volumn 295, Issue , 2005, Pages 55-79

  Plowe, C V ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; CARRIER PROTEIN; CHLOROQUINE; CHLORPROGUANIL PLUS DAPSONE; CYCLOGUANIL; DIHYDROFOLATE REDUCTASE; FANSIDAR; HALOFANTRINE; MEFLOQUINE; MULTIDRUG RESISTANCE PROTEIN 1; PROGUANIL; PYRIMETHAMINE; QUININE;

AFRICA; AGING; CLINICAL TRIAL; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG SUBSTITUTION; DRUG SURVEILLANCE PROGRAM; GENE MUTATION; GENETIC POLYMORPHISM; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; MALARIA; MALNUTRITION; MOLECULAR MECHANICS; MORBIDITY; MORTALITY; NONHUMAN; POPULATION DISTRIBUTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; RISK FACTOR; SCORING SYSTEM; TREATMENT FAILURE; WORLD HEALTH ORGANIZATION;

CINCHONA PUBESCENS; HUMAN IMMUNODEFICIENCY VIRUS; PLASMODIUM FALCIPARUM;

EID: 24144480947     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/3-540-29088-5_3     Document Type: Review

References (79)

1. Agarwal A, Guindo A, Cissoko, Y, Taylor JG, Coulibaly D, Kone A, Kayentao K, Djimde A, Plowe CV, Doumbo O, Wellems TE, Diallo D (2000) Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S. Blood 96:2358-2363
2. Attaran A, Barnes KI, Curtis C, D'Alessandro U, Fanello CI, Galinski MR, Kokwaro G, Looareesuwan S, Makanga M, Mutabingwa TK, Talisuna A, Trape J, Watkins WM (2004) WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 363:237-240
3. Baird JK, Purnomo, Basri H, Bangs MJ, Andersen EM, Jones TR, Masbar S, Harjosuwarno S, Subianto B, Arbani PR (1993) Age-specific prevalence of Plasmodium falciparum among six populations with limited histories of exposure to endemic malaria. Am J Trop Med Hyg 49:707-719
4. Bloland PB (2001) Drug resistance in malaria. WHO/CDS/CSR/DRS/2001.4. Geneva, WHO Department of Communicable Disease Surveillance and Response
5. Bloland PB, Ettling M (1999) Making malaria-treatment policy in the face of drug resistance. Ann Trop Med Parasitol 93:5-23
6. Bloland PB, Ettling M, Meek S (2000) Combination therapy for malaria in Africa: hype or hope? Bull World Health Organ 78:1378-1388
7. Bloland PB, Lackritz EM, Kazembe PN, Were JB, Steketee R, Campbell CC (1993) Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 167:932-937
8. Brooks DR, Wang P, Read M, Watkins WM, Sims PF, Hyde JE (1994) Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem 224:397-405
9. Cattamanchi A, Kyabayinze D, Hubbard A, Rosenthal PJ, Dorsey G (2003) Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: Comparison of results based on genotyping of MSP-1, MSP-2, and GLURP. Am J Trop Med Hyg 68:133-139
10. Cowman AF, Morry MJ, Biggs BA, Cross GA, Foote SJ (1988) Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 85:9109-9113
11. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su Xz, Nomura T, Fidock DA, Wellems TE, Plowe CV (2001a) A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 344:257-263
12. Djimde A, Doumbo OK, Steketee RW, Plowe CV (2001b) Application of a molecular marker for surveillance of chloroquine- resistant falciparum malaria. Lancet 358:890-891
13. Djimde AA, Doumbo OK, Traore O, Guindo AB, Kayentao K, Diourte Y, Niare-Doumbo S, Coulibaly D, Kone AK, Cissoko Y, Tekete M, Fofana B, Dicko A, Diallo DA, Wellems TE, Kwiatkowski D, Plowe CV (2003) Clearance of drug resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am J Trop Med Hyg 69:558-563
14. Dorsey G, Kamya MR, Singh A, Rosenthal PJ (2001) Polymorphisms in the Plasmodium falciparum PfCRT and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J Infect Dis 183:1417-1420
15. Dorsey G, Njama D, Kamya MR, Cattamanchi A, Kyabayinze D, Staedke SG, Gasasira A, Rosenthal PJ (2002) Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: A longitudinal randomised trial. Lancet 360:2031-2038
16. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC (2000) The tyrosine-86 allele of the PfMDR1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol 108:13-23
17. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sihdu AB, Naude B, Deitsch KW, Su X, Wootton JC, Roepe PD, Wellems TE (2000) Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6:861-871
18. Fidock DA, Nomura T, Wellems TE (1998) Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase. Mol Pharmacol 54:1140-1147
19. Fidock DA, Wellems, TE (1997) Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. Proc Natl Acad Sci USA 94:10931-10936
20. Foote SJ, Cowman, AF (1994) The mode of action and the mechanism of resistance to antimalarial drugs. Acta Trop 56:157-171
21. Foote SJ, Galatis D, Cowman AF (1990) Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci USA 87:3014-3017
22. Greenberg AE, Ntumbanzondo M, Ntula N, Mawa L, Howell J, Davachi F (1989) Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire. Bull World Health Organ 67:189-196
23. Hastings IM (1997) A model for the origins and spread of drug-resistant malaria. Parasitology 115:133-141
24. Hastings IM Mackinnon MJ (1998) The emergence of drug-resistant malaria. Parasitology 117:411-417
25. Hellgren U, Kihamia CM, Mahikwano LF, Bjorkman A, Eriksson O, Rombo L (1989) Response of Plasmodium falciparum to chloroquine treatment: Relation to whole blood concentrations of chloroquine and desethylchloroquine. Bull World Health Organ 67:197-202
26. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, Bennett S, Brewster D, McMichael AJ, Greenwood BM (1991) Common west African HLA antigens are associated with protection from severe malaria. Nature 352:595-600
27. Jelinek T, Aida AO, Peyerl-Hoffmann G, Jordan S, Mayor A, Heuschkel C, el Valy AO, von Sonnenburg F, Christophel EM (2002) Diagnostic value of molecular markers in chloroquine-resistant falciparum malaria in Southern Mauritania. Am J Trop Med Hyg 67:449-453
28. Koella JC Antia R (2003) Epidemiological models for the spread of anti-malarial resistance. Malar J 2:3
29. Kublin JG, Cortese JF, Njunju EM, Mukadam RAG Wirima JJ, Kazembe PN, Djimde AA, Kouriba B, Taylor TE, Plowe CV (2003) Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis 187:1870-1875
30. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV (2002) Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum Malaria. J Infect Dis 185:380-388
31. Lim AS, Galatis D, Cowman AF. (1996). Plasmodium falciparum: amplification and overexpression of PfMDR1 is not necessary for increased mefloquine resistance. Exp Parasitol. 83:295-303
32. Luxemburger C, Thwai KL, White NJ, Webster HK, Kyle DE, Maelankirri L, Chongsuphajaisiddhi T, Nosten F (1996) The epidemiology of malaria in a Karen population on the western border of Thailand. Trans R Soc Trop Med Hyg 90:105-111
33. Mackinnon MJ (1997) Survival probability of drug resistant mutants in malaria parasites. Proc Roy Soc Lond - Series B: Biological Sciences 264:53-59
34. Mayor AG, Gomez-Olive X, Aponte JJ, Casimiro S, Mabunda S, Dgedge M, Barreto A, Alonso PL (2001) Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (PfCRT) gene and its relation to chloroquine resistance in Mozambique. J Infect Dis 183:1413-1416
35. Mayxay M, Chotivanich K, Pukrittayakamee S, Newton P, Looareesuwan S, White NJ (2001) Contribution of humoral immunity to the therapeutic response in falciparum malaria. Am J Trop Med Hyg 65:918-923
36. Meshnick SR (2002) Artemisinin: Mechanisms of action, resistance and toxicity. Int J Parasitol 32:1655-1660
37. Miller LH, Carter R (1976) A review. Innate resistance in malaria. Exp Parasitol 40:132-146
38. Mita T, Kaneko A, Lum JK, Bwijo B, Takechi N, Zungu IL, Tsukahara T, Tanabe K, Kobayakawa T, Bjorkman A (2003) Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg 68:413-415
39. Modiano D, Luoni G, Sirima BS, Simpore J, Verra F, Konate A, Rastrelli E, Olivieri A, Calissano C, Paganotti GM, D'Urbano L, Sanou I, Sawadogo A, Modiano G, Coluzzi M (2001) Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 414:305-308
40. Mu J, Ferdig MT, Feng X, Joy DA, Duan J, Furuya T, Subramanian G, Aravind L, Cooper RA, Wootton JC, Xiong M, Su XZ. (2003). Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol Microbiol. 49:977-989
41. Mutabingwa T, Nzila A, Mberu E, Nduati E, Winstanley P, Hills E, Watkins W (2001a) Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet 358:1218-1223
42. Mutabingwa TK, Maxwell CA, Sia IG, Msuya FH, Mkongewa S, Vannithone S, Curtis J, Curtis CF (2001b) A trial of proguanil-dapsone in comparison with sulfadoxine-pyrimethamine for the clearance of Plasmodium falciparum infections in Tanzania. Trans R Soc Trop Med Hyg 95:433-438
43. Nguyen-Dinh, P Payne D (1980) Pyrimethamine sensitivity in Plasmodium falciparum: Determination in vitro by a modified 48-hour test. Bull World Health Organ 58:909-912
44. Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Luxemburger C, Webster HK, Edstein M, Phaipun L, Thew KL, White NJ (1991) Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 337:1140-1143
45. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, Muga R, Oloo AJ, Steketee RW (1998) Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 59:813-822
46. Paul RE, Packer MJ, Walmsley M, Lagog M, Ranford-Cartwright LC, Paru R, Day KP (1995) Mating patterns in malaria parasite populations of Papua New Guinea. Science 269:1709-1711
47. Peel SA, Bright P, Yount B, Handy J, Baric RS. (1994). A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro. Am J Trop Med Hyg. 51:648-658
48. Peterson DS, Milhous WK, Wellems TE (1990) Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci USA 87:3018-3022
49. Peterson DS, Walliker D, Wellems TE (1988) Evidence that a point mutation in dihydrofolate reductase- thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA 85:9114-9118
50. Pillai DR, Labbe AC, Vanisaveth V, Hongvangthong B, Pomphida S, Inkathone S, Zhong K, Kain KC (2001) Plasmodium falciparum malaria in Laos: Chloroquine treatment outcome and predictive value of molecular markers. J Infect Dis 183:789-795
51. Plowe CV, Doumbo OK, Djimde A, Kayentao K, Diourte Y, Doumbo SN, Coulibaly D, Thera M, Wellems TE, Diallo DA (2001) Chloroquine treatment of uncomplicated Plasmodium falciparum malaria in Mali: Parasitologic resistance versus therapeutic efficacy. Am J Trop Med Hyg 64:242-246
52. Plowe CV. (2003). Monitoring antimalarial drug resistance: making the most of the tools at hand. J Exp Biol 206:3745-3752.
53. Plowe CV, Kublin JG, Dzinjalamala FK, Kamwendo DS, Mukadam RA, Chimpeni P, Molyneux ME, Taylor TE (2004) Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: Five year prospective study. Br Med J 328:545-548
54. Price RN, Cassar C, Brockman A, Duraisingh M, van Vugt M, White NJ, Nosten F, Krishna S (1999) The PfMDR1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob Agents Chemother 43:2943-2949
55. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet 347:1654-1658
56. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF (2000) Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403:906-909
57. Ritchie GY, Mungthin M, Green JE, Bray PG, Hawley SR. Ward SA. (1996). In vitro selection of halofantrine resistance in Plasmodium falciparum is not associated with increased expression of Pgh1. Mol Biochem Parasitol 83:35-46
58. Roper C, Pearce R, Bredenkamp B, Gumede J, Drakeley C, Mosha F, Chandramohan D, Sharp B (2003) Antifolate antimalarial resistance in southeast Africa: A population-based analysis. Lancet 361:1174-1181
59. Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, Warn P, Allsopp CE, Gilbert SC, Peshu N (1995) Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376:246-249
60. Sidhu AB, Verdier-Pinard D, Fidock DA (2002) Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by PfCRT mutations. Science 298:210-213
61. Srivastava IK Vaidya AB (1999) A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Antimicrob Agents Chemother 43:1334-1339
62. Sulo J, Chimpeni P, Hatcher J, Kublin JG, Plowe CV, Molyneux ME, Marsh K, Taylor TE, Watkins WM, Winstanley PA (2002) Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: A randomised clinical trial. Lancet 360:1136-1143
63. Trape JF, Pison G, Preziosi MP, Enel C, Dulou AD, Delaunay V, Samb B, Lagarde E, Molez JF, Simondon F (1998) Impact of chloroquine resistance on malaria mortality. Comptes Rendus de l'Academie des Sciences de Paris/Life Sciences 321:689-697
64. van Hensbroek MB, Morris-Jones S, Meisner S, Jaffar S, Bayo L, Dackour R, Phillips C, Greenwood BM (1995) Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. Trans R Soc Trop Med Hyg 89:672-676
65. Viriyakosol S, Siripoon N, Petcharapirat C, Petcharapirat P, Jarra W, Brown KN, Snounou G (1995) Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies. Bull World Health Organ 73:85-95
66. Walker DJ, Pitsch JL, Peng MM, Robinson BL, Peters W, Bhisutthibhan J, Meshnick SR (2000) Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii. Antimicrob Agents Chemother 44:344-347
67. Watkins WM, Mberu EK, Nevill CG, Ward SA, Breckenridge AM, Koech DK (1990) Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults. Trans R Soc Trop Med Hyg 84:492-495
68. Wellems TE, Plowe CV (2001) Chloroquine-resistant malaria. J Infect Dis 184:770-776
69. White NJ (2002) The assessment of antimalarial drug efficacy. Trends Parasitol 18:458-464
70. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK, Danis M, Greenwood BM, Anderson RM, Olliaro P (1999) Averting a malaria disaster. Lancet 353:1965-1967
71. WHO (1973) Chemotherapy of malaria and resistance to antimalarials. 529. World Health Organization, Geneva. WHO Technical Report Series
72. WHO (1996) Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. Geneva, World Health Organization, Division of Control of Tropical Diseases
73. WHO (2002) Monitoring antimalarial drug resistance. Bloland PB, D'Alessandro, Ringwald, and Watkins. WHO/CDS/CSR/EPH/2002.17. Geneva, World Health Organization
74. Wilson CM, Volkman SK, Thaithong S, Martin RK, Kyle DE, Milhous WK, Wirth DF (1993) Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol Biochem Parasitol 57:151-160
75. Winstanley PA (2000) Chemotherapy for falciparum malaria: The armoury, the problems and the prospects. Parasitol Today 16:146-153
76. Wolday D, Kibreab T, Bukenya D, Hodes R (1995) Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire. Trans R Soc Trop Med Hyg 89:654-656
77. Zalis MG, Pang L, Silveira MS, Milhous WK, Wirth DF (1998) Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: Evidence for quinine resistance. Am J Trop Med Hyg 58:630-637
78. Zolg JW, Plitt JR, Chen GX, Palmer S (1989) Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Mol Biochem Parasitol 36:253-262
79. Zucker JR, Lackritz EM, Ruebush TK, Hightower AW, Adungosi JE, Were JB, Metchock B, Patrick E, Campbell CC (1996) Childhood mortality during and after hospitalization in western Kenya: Effect of malaria treatment regimens. Am J Trop Med Hyg 55:655-660